Our Firm has filed hundreds of cases in these two proceedings on behalf of women who allegedly suffered serious vaginal mesh complications from products manufactured by Ethicon and C.R. Bard. We are pleased to see this litigation moving forward.
(PRWEB) June 11, 2014
Thousands of transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/ ) filed on behalf of women who were allegedly injured by pelvic mesh products manufactured by C.R. Bard, Inc. and Ethicon, Inc. continue to move forward in multicounty litigations underway in New Jersey’s Atlantic County Superior Court, Bernstein Liebhard LLP reports. According to court documents, the litigations’ next Case Management Conference will be convened on Thursday, July 10th, at 10:00 a.m. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
“Our Firm has filed hundreds of cases in these two proceedings on behalf of women who allegedly suffered serious vaginal mesh complications from products manufactured by Ethicon and C.R. Bard. We are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free transvaginal mesh lawsuit reviews to women who suffered mesh erosion, pain, scarring, infection and other serious injuries, allegedly due to products manufactured by American Medical Systems, Inc., Boston Scientific Corp., C.R. Bard, Inc. and Ethicon, Inc.
Vaginal Mesh Litigation
Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving as Co-Liaison Counsel in both pelvic mesh litigations underway in New Jersey. Court records indicate that more than 1,257 transvaginal mesh lawsuits have been filed in the proceeding for claims involving C.R. Bard products, while more than 5,000 are pending in the Ethicon litigation. All of the lawsuits similarly allege that transvaginal mesh products marketed by the defendants were defectively designed and manufactured, and caused recipients
to suffer painful and debilitating vaginal mesh complications.
In addition to his role as Co-Liaison Counsel in these proceedings, Mr. Grand also served on the Plaintiff’s trial team for the first Ethicon trial in New Jersey, which ended in March 2013 with a jury awarding $11 million in compensatory and punitive damages to a woman who was harmed by the Ethicon Gynecare Prolift device. (Gross v. Gynecare Inc., Atl-L-6966-10)
According to court documents, more than 50,000 transvaginal mesh lawsuits are also pending in several litigations now underway in U.S. District Court, Southern District of West Virginia. Mr. Grand serves on the Plaintiffs’ Steering Committees for several of these multidistrict litigations, including those involving American Medical Systems, Inc. (MDL No. 2325), Boston Scientific Corp. (MDL No. 2326), C.R. Bard, Inc. (MDL No. 2187) and Ethicon, Inc. (MDL No. 2327).
Alleged victims of serious vaginal mesh complications may be entitled to compensation for medical bills and other injury-related damages. Find out more about filing a transvaginal mesh lawsuit by visiting Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP